Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 395 for “"Methotrexate"”.

  1. Evaluation of methotrexate polyglutamates as a biomarker for optimizing methotrexate treatment in Crohn’s disease

    Methotrexate (MTX) is an antagonist of folic acid metabolism that was initially designed to treat malignancies, including childhood leukemia. After its anti-inflammatory properties were discovered, use of MTX became widespread in the treatment algorithms for several autoimmune illnesses, including …

    bu Repository record for Evaluation of methotrexate polyglutamates as a biomarker for optimizing methotrexate treatment in Crohn’s disease (opens in a new tab)

  2. In Vitro Percutaneous Penetration Of Methotrexate

    … parameters on percutaneous penetration of methotrexate. The potential of propylene glycol in water as a vehicle for topical delivery of methotrexate has been examined. A detailed examination of solubility, partition coefficient and pH parameters in the range of 2 to 6 pH units has been …

    u-pacific Repository record for In Vitro Percutaneous Penetration Of Methotrexate (opens in a new tab)

  3. Effect of diet on methotrexate toxicity

    … regimens on gastrointestinal toxicity induced by methotrexate (MTX) in rats. Toxicity was determined by severity of anorexia and incidence of diarrhea on d 3 and 4 following an intraperitoneal injection of 20 mg MTX per kg body weight. Rats adapted to a casein-based semipurified diet for 14 d …

    uiuc Repository record for Effect of diet on methotrexate toxicity (opens in a new tab)

  4. Topical methotrexate: percutaneous penetration and clinical efficacy

    … the effectiveness of systemically administered methotrexate (MTX) in psoriasis, topical application of the drug has been suggested as a possible therapeutic regimen for the disease. However, controversy reigns over the clinical efficacy of such topical therapy and little is known of the …

    ubc Repository record for Topical methotrexate: percutaneous penetration and clinical efficacy (opens in a new tab) Download PDF for Topical methotrexate: percutaneous penetration and clinical efficacy (opens in a new tab)

  5. Methotrexate resistance in L5178Y mouse leukemia cells

    Methotrexate, a folic acid antagonist, has been used in the clinical treatment of a wide variety of malignant neoplasms for over 20 years, either as a single agent or in combination with other antineoplastic agents. It is a cell cycle specific inhibitor and kills cells only in the S phase of …

    ubc Repository record for Methotrexate resistance in L5178Y mouse leukemia cells (opens in a new tab) Download PDF for Methotrexate resistance in L5178Y mouse leukemia cells (opens in a new tab)

  6. Methotrexate resistance gene transfer in stem cells

    … that lentivirus-mediated transfer of a methotrexate (MTX) resistance gene, Tyr22-dihydrofolate reductase (Tyr22-DHFR), into stem cells would support long-term stable gene expression in vivo and protect hematopoietic daughter cells from MTX toxicity. To test our hypothesis, we first …

    umn Repository record for Methotrexate resistance gene transfer in stem cells (opens in a new tab)

  7. Intravitreal methotrexate for recurrent epiretinal membrane re-proliferation

    … persistence of this disease in some rare cases. Methotrexate although traditionally used to treat cancer and rheumatoid arthritis has been being explored as a treatment option in the field of ophthalmology for use against proliferative and migrating cellular diseases coupled with inflammation. …

    bu Repository record for Intravitreal methotrexate for recurrent epiretinal membrane re-proliferation (opens in a new tab)

  8. Morphologic Changes in Hair Growth Secondary to Methotrexate Toxicity

    Methotrexate, a commonly used chemotherapeutic agent, is known to exert its major effects, both therapeutic and toxic, against rapidly dividing cells. Unfortunately, the rapidly dividing healthy cells within the body are also affected. The hair follicle represents one such group of cells. Damage to …

    marquette Repository record for Morphologic Changes in Hair Growth Secondary to Methotrexate Toxicity (opens in a new tab)

  9. Efficacy of kynurenic acid and methotrexate in prevention of fibrosis

    … Another potential anti-fibrotic molecule is methotrexate (MTX). Systemic low dose MTX, which is a popular first line drug in the management of early and established rheumatoid arthritis (RA), has also been reported to be effective in prevention and treatment of keloid in few case reports. …

    ubc Repository record for Efficacy of kynurenic acid and methotrexate in prevention of fibrosis (opens in a new tab) Download PDF for Efficacy of kynurenic acid and methotrexate in prevention of fibrosis (opens in a new tab)

  10. Can curcumin improve the methotrexate based treatment for rheumatoid arthritis?

    … major concern due to the side effects involved. Methotrexate (MTX) is currently used as first line treatment due to its ability to modify the rheumatic conditions so that disease progression can be prevented. However, at the same time prolonged exposure to MTX can lead to severe side effects such …

    cent-lancashire Download PDF for Can curcumin improve the methotrexate based treatment for rheumatoid arthritis? (opens in a new tab)

  11. Low-dose methotrexate: not the hepatotoxic medication we once thought

    Methotrexate is a highly efficacious and frequently utilised disease-modifying medication. Concern regarding methotrexate-related hepatotoxicity has impeded the widespread application of the drug, despite a lack of high-quality evidence demonstrating a causal relationship. Methotrexate monitoring …

    whiterose Download PDF for Low-dose methotrexate: not the hepatotoxic medication we once thought (opens in a new tab)

Page 1 of 20